Going beyond systemic fluoropyrimidines with radiation therapy for rectal cancer: What should be the priority?

Dan G. Duda, Christopher G. Willett

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{b4ec6b9bcf394061a93aa43cbde02dec,

title = "Going beyond systemic fluoropyrimidines with radiation therapy for rectal cancer: What should be the priority?",

author = "Duda, \{Dan G.\} and Willett, \{Christopher G.\}",

year = "2012",

language = "English (US)",

volume = "26",

journal = "ONCOLOGY (United States)",

issn = "0890-9091",

publisher = "UBM Medica Healthcare Publications",

number = "8",

}

TY - JOUR

T1 - Going beyond systemic fluoropyrimidines with radiation therapy for rectal cancer

T2 - What should be the priority?

AU - Duda, Dan G.

AU - Willett, Christopher G.

PY - 2012

Y1 - 2012

UR - https://www.scopus.com/pages/publications/84874643032

UR - https://www.scopus.com/inward/citedby.url?scp=84874643032&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 22957407

AN - SCOPUS:84874643032

SN - 0890-9091

VL - 26

JO - ONCOLOGY (United States)

JF - ONCOLOGY (United States)

IS - 8

ER -